SCHEMBL24655982

SCHEMBL24655982

Cn1ccc2cc(C(C)(C)Cc3cc(C(C)(C)C)c4c(ccn4C)c3)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.40
CYP2A6 P11509 1/20 0.35
CHRNA7 P36544 4/20 0.33
ABL1 P00519 1/20 0.33
SRC P12931 1/20 0.33
KCNH2 Q12809 1/20 0.33
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
HIF1A Q16665 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22388515 0.73 PRKCI (0.49) PRKCICYP2A6CHRNA7ABL1SRC
SCHEMBL19499088 0.73 KCNH2 (0.34) PRKCIKCNH2CYP1A2CYP3A4TSHR
SCHEMBL2627061 0.73 PRKCI (0.55) PRKCICYP2A6ABL1SRCKCNH2
SCHEMBL18710631 0.71 PRKCI (0.46) PRKCICYP2A6CHRNA7ABL1SRC
SCHEMBL11955020 0.69 PRKCI (0.55) PRKCICYP2A6CHRNA7CYP19A1GRM2
SCHEMBL19119851 0.67 PRKCI (0.42) PRKCICYP2A6CHRNA7KCNH2CYP2D6
SCHEMBL1359850 0.66 PTGDR2 (0.33) PRKCI
SCHEMBL16205315 0.65 PRKCI (0.53) PRKCICYP2A6CHRNA7KCNH2CYP1A2
SCHEMBL29599343 0.65 PRKCI (0.53) PRKCICYP2A6CHRNA7KCNH2CYP1A2
SCHEMBL14506379 0.65 PRKCI (0.47) PRKCICYP2A6ABL1SRCKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP PRKCI 1350/4885CYP2A6 747/4885CHRNA7 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.